Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML

Acute myeloid leukaemia (AML) carrying internal tandem duplication (ITD) of Fms-Like Tyrosine kinase 3 (FLT3) gene is associated with high risk of relapse and poor clinical outcome upon treatment with conventional chemotherapy. FLT3 inhibitors have been approved for the treatment of this AML subtype...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Stephen S.Y., Leung, Anskar Y.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073218/
https://www.ncbi.nlm.nih.gov/pubmed/32102366
http://dx.doi.org/10.3390/ijms21041537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073218/
https://www.ncbi.nlm.nih.gov/pubmed/32102366
http://dx.doi.org/10.3390/ijms21041537

Ejemplares similares